That is very important, because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (tech stocks). But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. This was a breakthrough practically nobody saw. But it's going to have profound implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (first lady). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe considerably before going greater - jeff brown 1 biotech. I've been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the big question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. black sea. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal business on the edge of striking the public markets And I've been working on a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover out all the information. Go right here to schedule your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our typical beat (biotech stocks). And when it concerns tech investing, we leave it to the specialists. The good news is, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown predictions 2021). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and creating unbelievable opportunities for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown 2021 stock picks. But despite what many readers might believe, this is a trend that's just starting. Even though the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (future report review). Losing 2 months of manufacturing and sales truly impacts how lots of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is amazing. More importantly, the hold-ups brought on by the pandemic created a heap of bottled-up demand. And that demand is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - future report review. Which's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its three various stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services begin to be used (democratic republic). That's when we start to see applications working on 5G networks. Believe of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summertime. This begins something of a virtuous cycle: Most people do not actually appreciate the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable concept but with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For years, CRISPR was primarily a niche innovation that wasn't well comprehended. And during that time, there were truly only 3 business operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole industry is successfully a greenfield opportunity.
There's space for lots of companies to exist in this area. biotech stock. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or three more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can accurately predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That is essential since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced using this technology. This was one of those advancements that almost nobody saw. But it's going to have extensive implications for curing illness. And, of course, there will be plenty of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe significantly before going greater. I've been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - tech stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown 2021 stock picks. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, but we might not individually verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to select winning innovation stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent perspective on the market. He's constantly on the hunt for brand-new opportunities, and he shares a number of his best choices in the Near Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he effectively anticipated a few of the greatest economic events of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, but Jeff Brown's accurate predictions have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research study offers several research study services with a variety of expertises - genetic sequencer stock jeff brown.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - biotech stocks. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the very best investment research has actually not been offered to individual investors. It has been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. second wave. The objective of Brownstone Research is to make that sort of exclusive research study available to any financiers wanting to acquire an edge in the markets. The goal is basic to deliver unique and rewarding investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also functions as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you understand even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. last year. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. jeff brown top stock pick 2021. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two advanced innovations: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automotive industry's Holy Grail. As you understand, electrical cars and self-driving car stocks have actually been big this year, however the Wall Street machine has been huge on hype without much concrete outcome. Despite an extreme boost in competition over the past few years, Brown still believes Musk has the finest chance of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Car, and it could be the future of transportation. Generally, this technology would permit you to rent your automobile as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the automobile and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the earnings. It sounds outrageous, however it might be closed than you believe.